Humanization and molecular modeling of the anti-CD4 monoclonal antibody, OKT4A

Journal of Immunology

Volumn 156, Issue 8, 1996, Pages 2840-2850

  Pulito, Virginia L ^a   Roberts, Victoria A ^b   Adair, John R ^c,d   Rothermel, Annette L ^a   Collins, Alexander M ^a   Varga, Sally S ^a   Martocello, Cathy ^a   Bodmer, Mark ^c   Jolliffe, Linda K ^a   Zivin, Robert A ^a  

^a R W JOHNSON PHARMACEUTICAL RES I   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c UCB PHARMA   (Belgium)

^d Scotgen Biopharmaceuticals   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; HYBRID PROTEIN; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; MONOCLONAL ANTIBODY; OKT4A;

AMINO ACID SEQUENCE; ANIMAL; ANTIBODY AFFINITY; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER SIMULATION; GENETICS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; MIXED LYMPHOCYTE CULTURE; MOLECULAR CLONING; MOLECULAR GENETICS; MOUSE; SPECIES DIFFERENCE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY AFFINITY; ANTIGENS, CD4; CLONING, MOLECULAR; COMPUTER SIMULATION; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; LYMPHOCYTE CULTURE TEST, MIXED; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; RECOMBINANT FUSION PROTEINS; SPECIES SPECIFICITY;

EID: 0030584783     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Norman, D. J., W M. Bennett, A. Cobanoglu, R. Hershberger, J D. Hosenpud, M. M. Meyer, J Misiti, G Ott, R. Ratkovec, F. Shihab, C. Vitow, and J. M. Barry 1993 Use of OKT4A (a murine monoclonal anti-CD4 antibody) in human organ transplantation: initial clinical experience Transplant Proc. 25:802.
2. Lindsey, J. W., S. Hodgkinson, R. Metha, D. Mitchell, D. Enzmann, and L. Steinman. 1994. Repeated treatment with chimeric anti-CD4 antibody in multiple sclerosis. Ann. Neurol. 36:183.
3. Barker, J. N 1994. The immunopathology of psoriasis. Baillieres Clin. Rheumatol. 8:429.
4. Gorman, S. D., M. R. Clark, E. G Routledge, S. P. Cobbold, and H. Waldmann. 1991. Reshaping a therapeutic CD4 antibody. Proc. Natl. Acad Sci. USA 88: 4181.
5. Yocum, D. E , K. Nordensson, and A. M. Solloger. 1994. Immunomodulatory effect of Primatized IDEC-CE9.1, an anti CD4 monoclonal antibody, in RA. Arthritis Rheum. 37:S336.
6. Jonker, M., P. Neuhaus, V Zurcher, A. Fuccello, and G Goldstein. 1985. OKT4 and OKT4A antibody treatment as immunosuppression for kidney transplantation in rhesus monkeys. Transplantation 39:247.
7. Cosimi, A. B , F L Delmonico, J. K. Wright, S. L. Wee, F. T. Preffer, L K. Jolliffe, and R. B Colvin. 1990 Prolonged survival of nonhuman primate renal allograft recipients treated only with anti-CD4 monoclonal antibody. Surgery 108:406.
8. Van Lambalgen, R., and M. Jonker. 1987. Experimental allergic encephalomyelitis in rhesus monkeys. II. Treatment of EAE with anti-T lymphocyte subset monoclonal antibodies. Clin. Exp. Immunol. 68:305.
9. Jaffers, G. J., T. C. Fuller, A. B. Cosimi, P. S Russell, H. J. Winn, and R. B Colvin. 1986. Monoclonal antibody therapy anti-idiotypic and non-anti-idiotypic antibodies to OKT3 arising despite intense immunosuppression. Transplantation 41.572
10. Hammond, E. H., C. T. Wittwer, J. Greenwood, W. A Knape, R. L. Yowell, R. L. Menlove, C. Craven, D G Renlund, M R. Bristow, C. W. DeWitt, and J. B. O'Connell. 1990. Relationship of OKT3 sensitization and vascular rejection in cardiac transplant patients receiving OKT3 rejection prophylaxis. Transplantation 50:776.
11. Henell, K. R., J. M Cheever, J A Kimball, W. C. Lye, M. Y. Munar, J. Misiti, C. Vitow, and D. J. Norman 1993 OKT4A (a murine IgG2a anti-CD4 monoclonal antibody) in human organ transplantation: pharmacokinetics and peripheral pharmacodynamics. Transplant. Proc. 25.800.
12. Ortho Multi-Center Transplant Study Group. 1985. A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants. N. Engl. J. Med 313:337.
13. Morrison, S. L., M. J. Johnson, L A. Herzenberg, and V T. Oi 1984. Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains. Proc. Natl. Acad. Sci. USA 81:6851.
14. Looney, J E., D. M. Knight, M Arevalo-Moore, H. Trinh, K-Y. Pak, M. R. Dalesandro, E P Rieber, G. Riethmuller, and P E Daddona 1992. High level expression and characterization of a mouse-human chimeric CD4 antibody with theraputic potential. Hum Antibodies Hybridomas 3:191
15. Whittle, N., J Adair, J. Lloyd, L. Jenkins, J Devine, J. Schlom, A. Raubitschek, D. Colcher, and M Bodmer. 1987. Expression in COS cells of a mouse human chimeric B72 3 antibody. Protein Eng. 1:499.
16. Mountian, A., and J R Adair 1992. Engineering antibodies for therapy. Biotechnol. Genet. Eng. Rev. 10:1.
17. LoBuglio, A. F , R H. Wheeler, J Trang, A. Haynes, K Rogers, E. B. Harvey, L. Sun, J. Ghrayeb, and M. B Khazaeli. 1989 Mouse/human chimeric monoclonal antibody in man: kinetics and immune response. Proc. Natl Acad. Sci. USA 86.4220
18. Choy, E. H. S., A. Schantz, J. Woody, G. H. Kingsley, and G. S. Panayi. 1994. Human anti-chimeric antibody response in rheumatoid arthritis patients treated with a chimeric anti-CD4 monoclonal antibody. Arthritis Rheum 37:S340.
19. Reichmann, L , M. Clark, H. Waldmann, and G Winter. 1988. Reshaping human antibodies for therapy. Nature 332:323.
20. Jones, P. T., P. H. Dear, J. Foote, M S. Neuberger, and G. Winter. 1986. Replacing the complementarity-determining regions in a human antibody with those from a mouse. Nature 321.522.
21. Adair, J. R., D. S. Athwal, M. W. Bodmer, S M Brighi, A. M Collins, V. L Pulito, P. E Rao, R. Reedman, A. L. Rothermel, D. Xu, R. A. Zivin, and L. K Jolliffe. 1994. Humanization of the murine anti-human CD3 monoclonal antibody OKT3. Hum. Antibodies Hybridomas 5.41.
22. H residues 59 to 65. Proteins 18:49.
23. Sambrook, J., E. F. Fritsh, and T. Maniatis, 1989. Molecular Cloning: A Laboratory Manual, 2nd Ed. Cold Spring Harbor Press, Cold Spring Harbor.
24. Sanger, F , S. Nicklen, and A. R. Coulson 1977 DNA sequencing with chain-terminating inhibitors. Proc Natl. Acad. Sci. USA 74:5463.
25. Bernstein, F C., T. F. Koetzle, G. J. B Williams, E. F Meyer, Jr., M. D. Brice, J. R. Rodgers, O. Kennard, T. Shimanouchi, and M. Tasumi. 1977. The Protein Data Bank: a computer-based archival file for macromolecular structures. J Mol. Biol. 112.535.
26. Roberts, V A., B. L Iverson, S. A Iverson, S. J. Benkovic, R. A Lerner, E. D. Getzoff, and J. A. Tainer. 1990 Antibody remodeling: a general solution to the design of a metal-coordination site in an antibody binding pocket. Proc Natl. Acad Sci USA 87:6654.
27. Roberts, V. A., J. D. Stewart, S J. Benkovic, and E D. Getzoff. 1994. Catalytic antibody model and mutagenesis implicate arginine in transition-state stabilization. J. Mol. Biol 235.1098.
28. Chothia, C , and A M. Lesk. 1987 Canonical structures for the hypervariable regions of immunoglobulins. J. Mol. Biol 196:901.
29. Chothia, C., A. M. Lesk, A. Tramontano, M. Levitt, S J. Smith-Gill, G Air, S Sheriff, E A. Padlan, D. Davies, W R. Tulip, P. M. Colman, S. Spinelli, P M. Alzari, and R. J. Poljak 1989. Conformations of immunoglobulm hypervariable regions. Nature 342:877.
30. Chothia, C., J. Novotny, R. Bruccoleri, and M. Karplus 1985. Domain association in immunoglobulin molecules, the packing of variable domains. J. Mol. Biol. 186:651.
31. Laskowski, R. A , M. W MacArther, D. S. Moss, and J. M. Thornton. 1993. PROCHECK: a program to check the stereochemical quality of protein structures J Appl. Cryst 26 283.
32. Green, S., I. Issemann, and E Sheer. 1988. A versatile m vivo and in vitro eukaryotic expression vector for protein engineering. Nucleic Acids Res. 16.369.
33. Kozak, M. 1987. At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells. J. Mol. Biol. 196:947.
34. Kunkel, T. A. 1985. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc. Natl. Acad. Sci. USA 82:488.
35. Woodle, E. S., J. R. Thistlethwaite, L K Jolliffe, R. A. Zivin, A. Collins, J R Adair, M. Bodmer, D. Athwal, M. L Alergre, and J. A. Bluestone. 1992. Humanized OKT3 antibodies: successful transfer of immune modulating properties and idiotype expression. J. Immunol 148:2756.
36. Queen, C., W. P Schneider, H E. Selick, P. W. Payne, N. F. Landolfi, J. F. Duncan, N. M. Avdalovic, M. Levitt, R P Junghans, and T. A Waldmann. 1989. A humanized antibody that binds to the interleukin 2 receptor. Proc. Natl Acad Sci USA 86.10029.
37. Berzofsky, J A , and I. J. Berkower. 1984. Fundamental Immunology. W. E. Paul, ed. Raven, New York, pp. 595-644.
38. Bach, F. H., and N. K Voynow. 1966. One-way stimulation in mixed leukocyte cultures Science 153:545.
39. Rabat. E A , T. T. Wu, M. Reid-Miller, H M Perry, and K S. Gottesman. 1987. Sequences of Proteins of Immunological interest, 4th Ed. United States Department of Health and Human Services, Washington, D C.
40. Epp, O , E. E. Lattman, M. Schiffer, R Huber, and W. Palm. 1975. The molecular structure of a dimer composed of the variable portions of the Bence-Jones protein REI refined at 2.0-Å resolution. Biochemistry 14:4943.
41. Marquart, M., J. Deisenhofer, R Huber, and W. Palm. 1980 Crystallographic refinement and atomic models of the immunoglobulin molecule KOL and its antigen binding fragment at 3.0 Å and 1.9 Å resolution J Mol Biol 141:369.
42. Presta, L G., S J. Lahr, R. L. Shields, J P. Porter, C M. Gorman, B. M. Fendly, and P M. Jardieu. 1993. Humanization of an antibody directed against IgE. J. Immunol 151:2623.
43. Rose, D R., R. K. Strong, M N. Margolies, M. L Gefter, and G. A Petsko 1990. Crystal structure of the antigen-binding fragment of the murine anti-arsonate monoclonal antibody 36-71 at 2.9Å resolution. Proc Natl Acad. Sci. USA 87: 338
44. Stanfield, R L., T. M. Fieser, R. A. Lerner, and I. A. Wilson. 1990. Crystal structures of an antibody to a peptide and its complex with peptide antigen at 2.8Å. Science 248:712
45. H domains of immunoglobulins J. Mol. Biol. 215.175
46. Chien, N. C. V. A Roberts, A. M. Giusti, M D. Scharff, and E D Getzoff. 1989. Significant structural and functional change of an antigen-binding site by a distant amino acid substitution: proposal of a structural mechanism. Proc. Natl. Acad. Sci USA 86.5532.
47. Rini, J. M , U Schulze-Gahmen, and I. A. Wilson. 1992. Structural evidence for induced fit as a mechanism for antibody-antigen recognition. Science 255:959.
48. Foote, J , and G. Winter 1992. Antibody framework residues affecting the conformation of the hypervariable loops. J. Mol. Biol 224:487.
49. Adair, J R., D. S. Athwal, and J. S Emtage. 1991. Humanized antibodies: W091/09967.
50. Stewart, J D , V A Roberts, N. R. Thomas, E. D Getzoff, and S. J. Benkovic. 1994. Site-directed mutagenesis of a catalytic antibody: an arginine and a histidine residue play key roles. Biochemistry 33:1994.
51. Chen, C., V. A Roberts, and M. B. Rittenberg. 1992 Generation and analysis of random point mutations in an antibody CDR2 sequence: many mutated antibodies lose their ability to bind antigen. J. Exp. Med. 176 855.
52. Sato, K., M. Tsuchiya, J. Saldanha, Y. Koishihara, Y. Ohsugi, T. Kishimoto, and M. M. Bendig. 1993. Reshaping a human antibody to inhibit the interleukin 6-dependent tumor cell growth. Cancer Res. 53:851
53. Schildbach, J. F., R. I. Near, R. E. Bruccoleri, E Haber, P. D. Jeffrey, J. Novotny, S Sheriff, and M. N. Margolies. 1993. Modulation of antibody affinity by a non-contact residue. Protein Sci. 2:206.
54. Chen, C , V. A. Roberts, S. Stevens, M. Brown, M. P. Stenzel-Poore, and M. B. Rittenberg. 1995 Enhancement and destruction of antibody function by somatic mutation: unequal occurrence is controlled by V gene combinatorial associations. EMBO J. 14:2784.
55. Glockshuber, R., J. Stadlmuller, and A. Plückthun. 1991. Mapping and modification of an antibody hapten binding site: a site-directed mutagenesis study of McPC603. Biochemistry 30:3049.
56. Bedyzk, W D., J N. Herron, A. B. Edmundson, and E. W. Voss, Jr. 1990. Active site structure and antigen binding properties of idiotypically cross-reactive antifluorescein monoclonal antibodies. J. Biol. Chem 265.133.
57. Delmonico, F. L , and A. B Cosimi 1993. Nonhuman primate response to murine and humanized monoclonal antibodies. Transplant Proc. 25:65.
58. Delmonico, F. L., A. B. Cosimi, T Kawai, D. Cavender, W -H. Lee, L. K. Jolliffe, and R. W. Knowles. 1993. Nonhuman primate responses to murine and humanized OKT4A. Transplantation 55:722.
59. Cavender, D. E., D. Galler, G. Olim, and R. W. Knowles. 1995. Induction of tolerance in non-human primates with OKTcdr4a, a humanized anti-CD4 monoclonal antibody. The Immunologist. In press.
60. Hale, G., M R. Clark, R Marcus, G. Winter, M J S. Dyer, J. M. Phillips, L. Reichmann, and H. Waldmann. 1988. Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody Campath-1H. Lancet 2:1394.
61. Mathieson, P. W., S P. Cobbold, G. Hale, M. R Clark, D. B. Oliveira, C. M. Lockwood, and H. Waldmann 1990. Monoclonal-antibody therapy in systemic vasculitis. N. Engl. J. Med. 323:250.
62. Moreland, L. W., R P. Bucy, R W. Knowles, M. C. Wacholtz, T P Haverty, and W. J. Koopman. 1995. Treating rheumatoid arthritis with a non-depleting anti-CD4 monoclonal Ab (mAb) Arthritis Rheum 38:S186.
63. Sanner, M F., A. J. Olson, and J C. Spehner 1996. Reduced surface an efficient way to compute molecular surfaces. Biopolymers 38:305.